دورية أكاديمية
Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations
| العنوان: | Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations |
|---|---|
| المؤلفون: | Cortiula, Francesco, De Ruysscher, Dirk, Steens, Michelle, Wijsman, Robin, van der Wekken, Anthonie, Alberti, Martina, Hendriks, Lizza E.L. |
| المصدر: | In European Journal of Cancer May 2023 184:172-178 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2023.02.013 |